COVID-19 Vaccine Development Extends an Olive Branch for Growth of Biomarkers Market

Biomarkers are vital for identifying diseases in the human body. They are vital to the healthcare sector. The use of biomarkers in drug development also plays a vital role in the discovery of various drugs and vaccines necessary for curing a specific disease or disorder. Thus, the biomarkers market will bank greatly on this aspect across the forecast period of 2017-2025. The research and development activities for identifying certain biomarkers to provide insights in the discovery of new treatments will further bode well for multiplying the growth of biomarkers market.

Analysts are predicting a good growth rate across the forecast period owing to the various ongoing drug developments across the world and the widespread awareness about personalized medical care around the world. The use of blood samples for diagnosing whether an individual had a heart attack or not is a classic example highlighting the importance of biomarkers in the medical sector.

Get Sample Copy of this Report @

Biomarkers Proving To Be Helpful For SARS-Cov-2 Treatment

As the battle with the new coronavirus gets tougher day by day, efficient treatment to cure COVID-19 is the need of the hour. For this, the identification of biomarkers is necessary. The massive use of biomarkers as diagnostic tools in the new coronavirus vaccine trials is serving as the knight in shining armor for the growth of the biomarkers market. The major biomarkers used in clinical trials of COVID-19 are Coronavirus Nucleic Acid, Lymphocytes, SARS-CoV-2 RNA, and C-reactive protein. Biomarkers are also being used for determining the ideal drugs for treating COVID-19 patients, an essential factor to decrease the COVID-19 fatality rate worldwide. These aspects can bring good growth opportunities for the biomarkers market.

University of Melbourne researchers are gaining insights on how the immune system responds to the new coronavirus infection, which could be vital for vaccine research. B and T cell immune responses to coronavirus spike protein can act as helpful biomarkers for vaccine assessment in upcoming trials. Such developments may prove as growth generators for the biomarkers market.

The establishment of joint research initiatives to find biomarkers for COVID-19 can further promise good growth for the biomarkers market. For instance, the COVID-19 Spectrometry Coalition (COVID-19-MSC) consists of more than 500 scientists to research on biomarkers to analyze how an infected patient will respond to SARS-CoV-2, eventually leading to the discovery of new COVID-19 treatments.

Technological Advancements to Aid Biomarkers Market Growth

Various innovations in technology for blending biomarkers with drug development for different disorders and diseases are benefitting the biomarkers market greatly. Biomarkers can be used for treating various neurological disorders by tracking of the brain through biomolecules analysis. In addition, other developments such as biomarker signatures have the potential of inviting good growth opportunities for the biomarkers market.

Frequent merger and acquisition activities are turning the tables for the biomarkers market. Being a highly fragmented market, such activities help the key players cement their position more firmly in the biomarkers market. Key players in the biomarkers market are Enzo Biochem Inc., Biosims Technologies, Signosis Inc., and Perkinelmer, Inc.

Check Table of Contents of this Report @

North America may acquire a major chunk of growth for the biomarkers market. The U.S. is a leading country in the development of a potential vaccine. This will eventually lead to large-scale use of biomarkers, thus serving as a growth multiplier for the biomarkers market. Besides, growing demand for biomarkers across numerous industrial sectors in the region may propel the growth rate of the biomarkers market. Asia Pacific may also serve as a good growth contributor owing to the rising research and development activities revolving around the COVID-19 vaccine and increased outsourcing of pharmaceutical research and development activities.

Biomarkers Market Drive by Wide Range of Applications

San Francisco, California, January 04, 2018: Biomarkers Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025 is the latest report added by TMR Research which sheds light on the global market landscape of the biomarkers. The research report is a result of compilation of extensive primary as well as secondary research methodologies. The research report makes use of inputs from industry experts, surveys, and personal interviews to provide an in-depth qualitative as well as quantitative evaluation of the global biomarkers market. The report also consists of crucial information gathered from the prominent companies that are playing their trade in the global biomarkers market. A separate evaluation of the macro as well as micro-economic directives, driving factors of the market, current trends, mandates, and regulation that govern the overall development of the global market for biomarkers are also given out in the report.

A biomarker is considered as a natural molecule or gene which is being utilized widely over the globe with a specific end goal to assess exact pharmacologic reactions, organic methods, and pathogenic techniques. Likewise, biomarkers are utilized to check body’s reaction to a particular treatment for a condition or ailment. This helps the restorative experts in settling on powerful clinical choices, which will additionally help with diagnosing the soundness of patients. As indicated by the exploration consider, the worldwide biomarkers advertise is anticipated to enlist a dynamic development rate all through over the course of the given forecast period of 2017 to 2025.

Over the most few years, there has been a huge research on biomarkers, inferable from which the application fields are probably going to expand even more. This is projected to profit the global biomarkers market in the coming years. The utilization of biomarkers for successful therapeutics for cancer is probably going to create potential development openings. Likewise, the key players in the market are accentuating on emerging economies over the globe keeping in mind the end goal to make a specialty market landscape and enhance their quality and overall presence in the coming years of the given forecast period.

The global biomarkers market is seeing a great ascent in its valuation, on account of the expansion in diagnostic utilizations of biomarkers. The propelling investments for research and development activities in the pharma and biotech organizations, rising number of CROs, and the ease related with costs of the clinical trials in rising economies are additionally boosting this market. Going ahead, the high pervasiveness rate of cancer and novel activities for biomarker inquire about are probably going to push this market in the years to come.

However, on the down side, increasing requirement for capital investments and the minimal cost benefit ratio, different specialized issues related with gathering tests and their storage, and the inadequately suited administrative and repayment systems are probably going to act as impeding factors for the development of this market over the course of the given forecast period of 2017 to 2025.

The global market for biomarkers can be segmented into key regions such as North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Up to this point, North America, with majority share, has been driving the global market for biomarkers. With technological progressions and the growing focus on innovative research activities, this local market is probably going to stay dominant during the coming years of forecast period. Asia Pacific, among other local markets, is expected to witness high rate of development in the years to come, because of the presence of sufficient amount of raw materials.

Some of the key companies in the global market include names such as EKF Diagnostics Holdings Inc., Merck Millipore, Cisbio Biassasys Signosic Inc., and Meso Scale Diagnostics among others.

Get Sample Copy of this Report